Skip to main content
Log in

Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: Prevalence and percentage of positive tests in the employed diagnostic criteria

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The prevalence of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients is difficult to determine because the data in the literature are not homogeneous or comparable. ABPA and CF have similar clinical symptoms which make diagnosis difficult and underestimate the real dimensions of the problem. We conducted an epidemiological study on 3089 Italian CF patients to determine the prevalence of ABPA in Italy and verify the percentage of positive tests in the employed diagnostic criteria. Our results indicate that the prevalence of ABPA in Italian CF patients is 6.18%, mainly in adolescents and young adults. ABPA is diagnosed using clinical symptoms (presence of episodic bronchial obstructions or typical radiographic features) and on the basis of other criteria which can only be partially fulfilled in paediatric patients. Among the diagnostic tests the most sensitive are the total IgE (84.5%), specific IgE anti-Aspergillus fumigatus (81.6%) and the prick test (68.3%). In the absence of clinical symptoms and gold standard diagnostic tests, serological positivity and/or the skin test are not sufficient evidence to confirm the presence of ABPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105: 32–36.

    Google Scholar 

  2. Milla CE. Allergic bronchopulmonary aspergillosis and cystic fibrosis [editorial]. Pediatr Pulmonol 1999; 27: 71–73.

    Google Scholar 

  3. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis-a review and a report of eight cases. Thorax 1952; 7: 317–333.

    Google Scholar 

  4. Becker JW, Burke W, McDonald G, Greenberg PA, Henderson WR, Aitken ML. Prevalence of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis. Chest 1996; 109: 1536–1540.

    Google Scholar 

  5. Slavin RG. ABPA in CF: A devastating combination. Pediatr Pulmonol 1996; 21: 1–2.

    Google Scholar 

  6. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120: 863–873.

    Google Scholar 

  7. Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44–48.

    Google Scholar 

  8. Valletta EA, Braggion C, Mastella G. Sensitization to Aspergillus and allergic bronchopulmonary aspergillosis in a cystic fibrosis population. Pediatric Asthma, Allergy & Immunology 1993; 7: 43–49.

    Google Scholar 

  9. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J. Is ABPA a serious complication? The European Epidemiology Registry of Cystic Fibrosis Workbook. 22nd European Cystic Fibrosis Conference. Berlin, June 18, 1998.

  10. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405–414.

    Google Scholar 

  11. Patterson R, Greenberg PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 1982; 96: 286–291.

    Google Scholar 

  12. Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol 1991; 88: 390–394.

    Google Scholar 

  13. Wang JLF, Patterson R, Rosenberg M, Roberts M, Cooper BJ. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978; 117: 917–927.

    Google Scholar 

  14. Goodchild MC, Watson E. Diagnostic methods and screening. In: Hodson ME, Geddes D (eds), Cystic Fibrosis, London: Chapman & Hall, 1995; 179–211.

    Google Scholar 

  15. Mannes GPM. Clinical manifestations of Aspergillus fumigatus in children and adults with CF. Neth J Med 1999; 54 (Suppl): 11–12.

    Google Scholar 

  16. Wilmott RW, Kravitz RM. Allergic bronchopulmonary aspergillosis. In: Hilman BC (ed), Pediatric Respiratory Disease, Philadelphia: Saunders, 1993; 692–697.

    Google Scholar 

  17. Hiller EJ. Aspergillosis. J R Soc Med 1992; 85 (Suppl 19): 33–35.

    Google Scholar 

  18. Report of the Consensus Conference on Microbiology and Infectious Disease in Cystic Fibrosis. 17–19 May, 1994, Bethesda, MD.

  19. Gondor M, Michaelst MG, Finder JD: Non-aspergius allergic bronchopulmonary mycosis in a pediatric patient with cystic fibrosis. Pediatrics 1998; 102: 1480–1482.

    Google Scholar 

  20. Cystic Fibrosis Foundation. Patient Registry 1997 Annual Data Report. Bethesda, MD, September 1998.

  21. Padoan R, Marzano MT, Giunta A. Allergic bronchopulmonary aspergillosis in cystic fibrosis: 2 cases of ABPA in children under 5 years. Israel J Med Sci 1996; 32 (Suppl): S172.

    Google Scholar 

  22. Greenberg PA. Immunologic aspects of lung diseases and cystic fibrosis. JAMA 1997; 278: 1924–1930.

    Google Scholar 

  23. Hodson ME. Respiratory system-adults. In: Hodson ME, Geddes D (eds), Cystic Fibrosis, London: Chapman & Hall, 1995; 237–257.

    Google Scholar 

  24. McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol 1970; 21: 366–375.

    Google Scholar 

  25. Hutcheson PS, Knutsen AP, Rejent A, Slavin R. A 12-year longitudinal study of Aspergillus fumigatus sensitivity in patients with cystic fibrosis. Chest 1996; 110: 363–366.

    Google Scholar 

  26. Wojnarowski Eichler I, Gartner C, Gotz M, Renner S, Koller DY, Frischer T. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997; 155: 1902–1905.

    Google Scholar 

  27. Dreborg S, Frew A. Allergen standardization and skin tests. Allergy 1993; 14 (Suppl): 49–82.

    Google Scholar 

  28. Holland SM, Gallin JI. Disorders of granulocytes and monocytes. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds), Harrison's Principles of Internal Medicine, New York: McGraw-Hill, 1998; 351–359.

    Google Scholar 

  29. Schwartz RH, Johnstone D, Holsclaw DS, Dooley RR. Serum precipitins to Aspergillus fumigatus in cystic fibrosis patients. Am J Dis Child 1970; 120: 432–433.

    Google Scholar 

  30. Nikolaizik WH, Moser M, Cramery R, et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995; 152: 634–639.

    Google Scholar 

  31. Taccetti G, Campana S. Microbiologic data overview of Italian cystic fibrosis patients. Eur J Epidemiol 1997; 13: 323–327.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taccetti, G., Procopio, E., Marianelli, L. et al. Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: Prevalence and percentage of positive tests in the employed diagnostic criteria. Eur J Epidemiol 16, 837–842 (2000). https://doi.org/10.1023/A:1007670717619

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007670717619

Navigation